Citation Impact
Citing Papers
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
2017
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
2008 Standout
Cancer statistics, 2022
2022 Standout
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Triple negative breast cancer: unmet medical needs
2010
Triple negative tumours: a critical review
2007
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes
2010
Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
2010
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
The role of HER2 in cancer therapy and targeted drug delivery
2010
Triple-Negative Breast Cancer: An Unmet Medical Need
2011
Inference and analysis of cell-cell communication using CellChat
2021 Standout
AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network
2020
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
2014
A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
2011
Triple-Negative Breast Cancer: Correlation between MR Imaging and Pathologic Findings
2009
Triple-Negative Breast Cancer
2010 Standout
Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System
2017
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
2008 Standout
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Breast cancer
2016 Standout
Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group
2009
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Novel Treatment Approaches for Triple-Negative Breast Cancer
2010
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Pancreatic cancer
2016 Standout
Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer
2015
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Pancreatic Adenocarcinoma
2014 Standout
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Cancer statistics for Hispanics/Latinos, 2012
2012
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
U1 snRNP regulates cancer cell migration and invasion in vitro
2020 Standout
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial
2018
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
2010
Epidemiology of basal-like breast cancer
2007
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Clonal evolution in cancer
2012 StandoutNature
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
2007
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
2011 Standout
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors
2015
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
2014
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
2016 Standout
Bladder Cancer
2020 Standout
Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor–Positive Breast Cancer
2011
Breast Cancer Treatment
2019 Standout
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995-2008.
2014
Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer
2015
Cancer statistics, 2016
2016 Standout
Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
2012
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
2016
Cancer statistics, 2015
2015 Standout
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
2012
Au Nanomatryoshkas as Efficient Near-Infrared Photothermal Transducers for Cancer Treatment: Benchmarking against Nanoshells
2014
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Cancer statistics, 2014
2014 Standout
Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
2013
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Age/Race Differences in HER2 Testing and in Incidence Rates for Breast Cancer Triple Subtypes: A Population-Based Study and First Report
2010
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Works of Katrina Bauer being referenced
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype
2007 Standout
Variation in breast cancer subtypes with age and race/ethnicity
2009
Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer
2010
Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004
2009
The impact of socioeconomic status on survival after cancer in the United States
2008
Disparities in receipt of adjuvant radiation therapy after breast‐conserving surgery among the cancer‐reporting regions of California
2011
The Implications of Age and Comorbidity on Survival Following Epithelial Ovarian Cancer: Summary and Results from a Centers for Disease Control and Prevention Study
2012
Quality of cancer registry data: findings from CDC-NPCR's Breast and Prostate Cancer Data Quality and Patterns of Care Study.
2011